Detalhe da pesquisa
1.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Lancet;
403(10427): 645-656, 2024 Feb 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38278170
2.
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
Circulation;
144(14): 1104-1116, 2021 10 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34380322
3.
Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Circulation;
142(23): 2219-2230, 2020 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33138628
4.
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.
Cancer Med;
12(16): 16859-16868, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37458138
5.
Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
J Am Coll Cardiol;
78(18): 1768-1778, 2021 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34711335